<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2000-05-30" modified="2017-05-10" version="202">
<accession>O96017</accession>
<accession>A8K3Y9</accession>
<accession>B7ZBF3</accession>
<accession>B7ZBF4</accession>
<accession>B7ZBF5</accession>
<accession>Q6QA03</accession>
<accession>Q6QA04</accession>
<accession>Q6QA05</accession>
<accession>Q6QA06</accession>
<accession>Q6QA07</accession>
<accession>Q6QA08</accession>
<accession>Q6QA10</accession>
<accession>Q6QA11</accession>
<accession>Q6QA12</accession>
<accession>Q6QA13</accession>
<accession>Q9HBS5</accession>
<accession>Q9HCQ8</accession>
<accession>Q9UGF0</accession>
<accession>Q9UGF1</accession>
<name>CHK2_HUMAN</name>
<protein>
<recommendedName>
<fullName>Serine/threonine-protein kinase Chk2</fullName>
<ecNumber>2.7.11.1</ecNumber>
</recommendedName>
<alternativeName>
<fullName>CHK2 checkpoint homolog</fullName>
</alternativeName>
<alternativeName>
<fullName>Cds1 homolog</fullName>
<shortName>Hucds1</shortName>
<shortName>hCds1</shortName>
</alternativeName>
<alternativeName>
<fullName>Checkpoint kinase 2</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">CHEK2</name>
<name type="synonym">CDS1</name>
<name type="synonym">CHK2</name>
<name type="synonym">RAD53</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1998" name="Science" volume="282" first="1893" last="1897">
<title>Linkage of ATM to cell cycle regulation by the Chk2 protein kinase.</title>
<authorList>
<person name="Matsuoka S."/>
<person name="Huang M."/>
<person name="Elledge S.J."/>
</authorList>
<dbReference type="PubMed" id="9836640"/>
<dbReference type="DOI" id="10.1126/science.282.5395.1893"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>FUNCTION IN PHOSPHORYLATION OF CDC25C</scope>
<scope>MUTAGENESIS OF ASP-347</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1999" name="Curr. Biol." volume="9" first="1" last="10">
<title>A human homologue of the checkpoint kinase Cds1 directly inhibits Cdc25 phosphatase.</title>
<authorList>
<person name="Blasina A."/>
<person name="van de Weyer I."/>
<person name="Laus M.C."/>
<person name="Luyten W.H.M.L."/>
<person name="Parker A.E."/>
<person name="McGowan C.H."/>
</authorList>
<dbReference type="PubMed" id="9889122"/>
<dbReference type="DOI" id="10.1016/S0960-9822(99)80041-4"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>FUNCTION IN MITOSIS</scope>
</reference>
<reference key="3">
<citation type="journal article" date="1999" name="Proc. Natl. Acad. Sci. U.S.A." volume="96" first="3745" last="3750">
<title>A human Cds1-related kinase that functions downstream of ATM protein in the cellular response to DNA damage.</title>
<authorList>
<person name="Brown A.L."/>
<person name="Lee C.-H."/>
<person name="Schwarz J.K."/>
<person name="Mitiku N."/>
<person name="Piwnica-Worms H."/>
<person name="Chung J.H."/>
</authorList>
<dbReference type="PubMed" id="10097108"/>
<dbReference type="DOI" id="10.1073/pnas.96.7.3745"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2)</scope>
<scope>FUNCTION IN PHOSPHORYLATION OF CDC25C</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2004" name="Oncogene" volume="23" first="8535" last="8544">
<title>Alternative splicing and mutation status of CHEK2 in stage III breast cancer.</title>
<authorList>
<person name="Staalesen V."/>
<person name="Falck J."/>
<person name="Geisler S."/>
<person name="Bartkova J."/>
<person name="Boerresen-Dale A.-L."/>
<person name="Lukas J."/>
<person name="Lillehaug J.R."/>
<person name="Bartek J."/>
<person name="Lonning P.E."/>
</authorList>
<dbReference type="PubMed" id="15361853"/>
<dbReference type="DOI" id="10.1038/sj.onc.1207928"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2; 3; 4; 5; 6; 7; 8; 9; 10; 11 AND 12)</scope>
<scope>SUBCELLULAR LOCATION</scope>
<source>
<tissue>Mammary gland</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="2004" name="Genome Biol." volume="5" first="R84.1" last="R84.11">
<title>A genome annotation-driven approach to cloning the human ORFeome.</title>
<authorList>
<person name="Collins J.E."/>
<person name="Wright C.L."/>
<person name="Edwards C.A."/>
<person name="Davis M.P."/>
<person name="Grinham J.A."/>
<person name="Cole C.G."/>
<person name="Goward M.E."/>
<person name="Aguado B."/>
<person name="Mallya M."/>
<person name="Mokrab Y."/>
<person name="Huckle E.J."/>
<person name="Beare D.M."/>
<person name="Dunham I."/>
</authorList>
<dbReference type="PubMed" id="15461802"/>
<dbReference type="DOI" id="10.1186/gb-2004-5-10-r84"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 9)</scope>
</reference>
<reference key="6">
<citation type="submission" date="1999-07" db="EMBL/GenBank/DDBJ databases">
<title>Chk2/HuCds1 cell cycle checkpoint protein kinase from human colon carcinoma HT29 cells: regulation by autophosphorylation and DNA-dependent protein kinase and inhibition by cell cycle regulatory drugs.</title>
<authorList>
<person name="Shao R.-G."/>
<person name="Zhang H."/>
<person name="Yu Q."/>
<person name="Pommier Y."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Colon carcinoma</tissue>
</source>
</reference>
<reference key="7">
<citation type="submission" date="2000-03" db="EMBL/GenBank/DDBJ databases">
<title>An alternative spliced Chk2.</title>
<authorList>
<person name="Ogawa A."/>
<person name="Okabe-Nakamura A."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 12)</scope>
<source>
<tissue>T-cell</tissue>
</source>
</reference>
<reference key="8">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2004" name="Proc. Natl. Acad. Sci. U.S.A." volume="101" first="15724" last="15729">
<title>Large-scale cDNA transfection screening for genes related to cancer development and progression.</title>
<authorList>
<person name="Wan D."/>
<person name="Gong Y."/>
<person name="Qin W."/>
<person name="Zhang P."/>
<person name="Li J."/>
<person name="Wei L."/>
<person name="Zhou X."/>
<person name="Li H."/>
<person name="Qiu X."/>
<person name="Zhong F."/>
<person name="He L."/>
<person name="Yu J."/>
<person name="Yao G."/>
<person name="Jiang H."/>
<person name="Qian L."/>
<person name="Yu Y."/>
<person name="Shu H."/>
<person name="Chen X."/>
<person name="Xu H."/>
<person name="Guo M."/>
<person name="Pan Z."/>
<person name="Chen Y."/>
<person name="Ge C."/>
<person name="Yang S."/>
<person name="Gu J."/>
</authorList>
<dbReference type="PubMed" id="15498874"/>
<dbReference type="DOI" id="10.1073/pnas.0404089101"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 13)</scope>
</reference>
<reference key="10">
<citation type="submission" date="2004-10" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="NIEHS SNPs program"/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANTS LEU-85; THR-157; MET-436; LYS-446; ILE-447; SER-448; LYS-501 AND VAL-512</scope>
</reference>
<reference key="11">
<citation type="journal article" date="1999" name="Nature" volume="402" first="489" last="495">
<title>The DNA sequence of human chromosome 22.</title>
<authorList>
<person name="Dunham I."/>
<person name="Hunt A.R."/>
<person name="Collins J.E."/>
<person name="Bruskiewich R."/>
<person name="Beare D.M."/>
<person name="Clamp M."/>
<person name="Smink L.J."/>
<person name="Ainscough R."/>
<person name="Almeida J.P."/>
<person name="Babbage A.K."/>
<person name="Bagguley C."/>
<person name="Bailey J."/>
<person name="Barlow K.F."/>
<person name="Bates K.N."/>
<person name="Beasley O.P."/>
<person name="Bird C.P."/>
<person name="Blakey S.E."/>
<person name="Bridgeman A.M."/>
<person name="Buck D."/>
<person name="Burgess J."/>
<person name="Burrill W.D."/>
<person name="Burton J."/>
<person name="Carder C."/>
<person name="Carter N.P."/>
<person name="Chen Y."/>
<person name="Clark G."/>
<person name="Clegg S.M."/>
<person name="Cobley V.E."/>
<person name="Cole C.G."/>
<person name="Collier R.E."/>
<person name="Connor R."/>
<person name="Conroy D."/>
<person name="Corby N.R."/>
<person name="Coville G.J."/>
<person name="Cox A.V."/>
<person name="Davis J."/>
<person name="Dawson E."/>
<person name="Dhami P.D."/>
<person name="Dockree C."/>
<person name="Dodsworth S.J."/>
<person name="Durbin R.M."/>
<person name="Ellington A.G."/>
<person name="Evans K.L."/>
<person name="Fey J.M."/>
<person name="Fleming K."/>
<person name="French L."/>
<person name="Garner A.A."/>
<person name="Gilbert J.G.R."/>
<person name="Goward M.E."/>
<person name="Grafham D.V."/>
<person name="Griffiths M.N.D."/>
<person name="Hall C."/>
<person name="Hall R.E."/>
<person name="Hall-Tamlyn G."/>
<person name="Heathcott R.W."/>
<person name="Ho S."/>
<person name="Holmes S."/>
<person name="Hunt S.E."/>
<person name="Jones M.C."/>
<person name="Kershaw J."/>
<person name="Kimberley A.M."/>
<person name="King A."/>
<person name="Laird G.K."/>
<person name="Langford C.F."/>
<person name="Leversha M.A."/>
<person name="Lloyd C."/>
<person name="Lloyd D.M."/>
<person name="Martyn I.D."/>
<person name="Mashreghi-Mohammadi M."/>
<person name="Matthews L.H."/>
<person name="Mccann O.T."/>
<person name="Mcclay J."/>
<person name="Mclaren S."/>
<person name="McMurray A.A."/>
<person name="Milne S.A."/>
<person name="Mortimore B.J."/>
<person name="Odell C.N."/>
<person name="Pavitt R."/>
<person name="Pearce A.V."/>
<person name="Pearson D."/>
<person name="Phillimore B.J.C.T."/>
<person name="Phillips S.H."/>
<person name="Plumb R.W."/>
<person name="Ramsay H."/>
<person name="Ramsey Y."/>
<person name="Rogers L."/>
<person name="Ross M.T."/>
<person name="Scott C.E."/>
<person name="Sehra H.K."/>
<person name="Skuce C.D."/>
<person name="Smalley S."/>
<person name="Smith M.L."/>
<person name="Soderlund C."/>
<person name="Spragon L."/>
<person name="Steward C.A."/>
<person name="Sulston J.E."/>
<person name="Swann R.M."/>
<person name="Vaudin M."/>
<person name="Wall M."/>
<person name="Wallis J.M."/>
<person name="Whiteley M.N."/>
<person name="Willey D.L."/>
<person name="Williams L."/>
<person name="Williams S.A."/>
<person name="Williamson H."/>
<person name="Wilmer T.E."/>
<person name="Wilming L."/>
<person name="Wright C.L."/>
<person name="Hubbard T."/>
<person name="Bentley D.R."/>
<person name="Beck S."/>
<person name="Rogers J."/>
<person name="Shimizu N."/>
<person name="Minoshima S."/>
<person name="Kawasaki K."/>
<person name="Sasaki T."/>
<person name="Asakawa S."/>
<person name="Kudoh J."/>
<person name="Shintani A."/>
<person name="Shibuya K."/>
<person name="Yoshizaki Y."/>
<person name="Aoki N."/>
<person name="Mitsuyama S."/>
<person name="Roe B.A."/>
<person name="Chen F."/>
<person name="Chu L."/>
<person name="Crabtree J."/>
<person name="Deschamps S."/>
<person name="Do A."/>
<person name="Do T."/>
<person name="Dorman A."/>
<person name="Fang F."/>
<person name="Fu Y."/>
<person name="Hu P."/>
<person name="Hua A."/>
<person name="Kenton S."/>
<person name="Lai H."/>
<person name="Lao H.I."/>
<person name="Lewis J."/>
<person name="Lewis S."/>
<person name="Lin S.-P."/>
<person name="Loh P."/>
<person name="Malaj E."/>
<person name="Nguyen T."/>
<person name="Pan H."/>
<person name="Phan S."/>
<person name="Qi S."/>
<person name="Qian Y."/>
<person name="Ray L."/>
<person name="Ren Q."/>
<person name="Shaull S."/>
<person name="Sloan D."/>
<person name="Song L."/>
<person name="Wang Q."/>
<person name="Wang Y."/>
<person name="Wang Z."/>
<person name="White J."/>
<person name="Willingham D."/>
<person name="Wu H."/>
<person name="Yao Z."/>
<person name="Zhan M."/>
<person name="Zhang G."/>
<person name="Chissoe S."/>
<person name="Murray J."/>
<person name="Miller N."/>
<person name="Minx P."/>
<person name="Fulton R."/>
<person name="Johnson D."/>
<person name="Bemis G."/>
<person name="Bentley D."/>
<person name="Bradshaw H."/>
<person name="Bourne S."/>
<person name="Cordes M."/>
<person name="Du Z."/>
<person name="Fulton L."/>
<person name="Goela D."/>
<person name="Graves T."/>
<person name="Hawkins J."/>
<person name="Hinds K."/>
<person name="Kemp K."/>
<person name="Latreille P."/>
<person name="Layman D."/>
<person name="Ozersky P."/>
<person name="Rohlfing T."/>
<person name="Scheet P."/>
<person name="Walker C."/>
<person name="Wamsley A."/>
<person name="Wohldmann P."/>
<person name="Pepin K."/>
<person name="Nelson J."/>
<person name="Korf I."/>
<person name="Bedell J.A."/>
<person name="Hillier L.W."/>
<person name="Mardis E."/>
<person name="Waterston R."/>
<person name="Wilson R."/>
<person name="Emanuel B.S."/>
<person name="Shaikh T."/>
<person name="Kurahashi H."/>
<person name="Saitta S."/>
<person name="Budarf M.L."/>
<person name="McDermid H.E."/>
<person name="Johnson A."/>
<person name="Wong A.C.C."/>
<person name="Morrow B.E."/>
<person name="Edelmann L."/>
<person name="Kim U.J."/>
<person name="Shizuya H."/>
<person name="Simon M.I."/>
<person name="Dumanski J.P."/>
<person name="Peyrard M."/>
<person name="Kedra D."/>
<person name="Seroussi E."/>
<person name="Fransson I."/>
<person name="Tapia I."/>
<person name="Bruder C.E."/>
<person name="O'Brien K.P."/>
<person name="Wilkinson P."/>
<person name="Bodenteich A."/>
<person name="Hartman K."/>
<person name="Hu X."/>
<person name="Khan A.S."/>
<person name="Lane L."/>
<person name="Tilahun Y."/>
<person name="Wright H."/>
</authorList>
<dbReference type="PubMed" id="10591208"/>
<dbReference type="DOI" id="10.1038/990031"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="12">
<citation type="submission" date="2005-07" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Muscle</tissue>
</source>
</reference>
<reference key="14">
<citation type="journal article" date="2000" name="Nature" volume="404" first="201" last="204">
<title>hCds1-mediated phosphorylation of BRCA1 regulates the DNA damage response.</title>
<authorList>
<person name="Lee J.S."/>
<person name="Collins K.M."/>
<person name="Brown A.L."/>
<person name="Lee C.H."/>
<person name="Chung J.H."/>
</authorList>
<dbReference type="PubMed" id="10724175"/>
<dbReference type="DOI" id="10.1038/35004614"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF BRCA1</scope>
<scope>INTERACTION WITH BRCA1</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2000" name="Proc. Natl. Acad. Sci. U.S.A." volume="97" first="10389" last="10394">
<title>Ataxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro.</title>
<authorList>
<person name="Matsuoka S."/>
<person name="Rotman G."/>
<person name="Ogawa A."/>
<person name="Shiloh Y."/>
<person name="Tamai K."/>
<person name="Elledge S.J."/>
</authorList>
<dbReference type="PubMed" id="10973490"/>
<dbReference type="DOI" id="10.1073/pnas.190030497"/>
</citation>
<scope>PHOSPHORYLATION AT THR-68 BY ATM</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="30537" last="30541">
<title>The hCds1 (Chk2)-FHA domain is essential for a chain of phosphorylation events on hCds1 that is induced by ionizing radiation.</title>
<authorList>
<person name="Lee C.H."/>
<person name="Chung J.H."/>
</authorList>
<dbReference type="PubMed" id="11390408"/>
<dbReference type="DOI" id="10.1074/jbc.M104414200"/>
</citation>
<scope>PHOSPHORYLATION AT THR-383 AND THR-387</scope>
<scope>MUTAGENESIS OF THR-383 AND THR-387</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2001" name="Nature" volume="410" first="842" last="847">
<title>The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis.</title>
<authorList>
<person name="Falck J."/>
<person name="Mailand N."/>
<person name="Syljuaasen R.G."/>
<person name="Bartek J."/>
<person name="Lukas J."/>
</authorList>
<dbReference type="PubMed" id="11298456"/>
<dbReference type="DOI" id="10.1038/35071124"/>
</citation>
<scope>FUNCTION IN INTRA S-PHASE CHECKPOINT</scope>
<scope>FUNCTION IN PHOSPHORYLATION OF CDC25A</scope>
<scope>INTERACTION WITH CDC25A</scope>
<scope>MUTAGENESIS OF ASP-347</scope>
<scope>CHARACTERIZATION OF VARIANT COLON CANCER TRP-145</scope>
<scope>CHARACTERIZATION OF VARIANT THR-157</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2002" name="Am. J. Hum. Genet." volume="71" first="432" last="438">
<title>A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer.</title>
<authorList>
<person name="Vahteristo P."/>
<person name="Bartkova J."/>
<person name="Eerola H."/>
<person name="Syrjakoski K."/>
<person name="Ojala S."/>
<person name="Kilpivaara O."/>
<person name="Tamminen A."/>
<person name="Kononen J."/>
<person name="Aittomaki K."/>
<person name="Heikkila P."/>
<person name="Holli K."/>
<person name="Blomqvist C."/>
<person name="Bartek J."/>
<person name="Kallioniemi O.P."/>
<person name="Nevanlinna H."/>
</authorList>
<dbReference type="PubMed" id="12094328"/>
<dbReference type="DOI" id="10.1086/341943"/>
</citation>
<scope>INVOLVEMENT IN SUSCEPTIBILITY TO BC</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="19389" last="19395">
<title>Phosphorylation of threonine 68 promotes oligomerization and autophosphorylation of the Chk2 protein kinase via the forkhead-associated domain.</title>
<authorList>
<person name="Ahn J.Y."/>
<person name="Li X."/>
<person name="Davis H.L."/>
<person name="Canman C.E."/>
</authorList>
<dbReference type="PubMed" id="11901158"/>
<dbReference type="DOI" id="10.1074/jbc.M200822200"/>
</citation>
<scope>HOMODIMERIZATION</scope>
<scope>AUTOPHOSPHORYLATION</scope>
<scope>MUTAGENESIS OF THR-68</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2002" name="Nat. Cell Biol." volume="4" first="865" last="870">
<title>PML-dependent apoptosis after DNA damage is regulated by the checkpoint kinase hCds1/Chk2.</title>
<authorList>
<person name="Yang S."/>
<person name="Kuo C."/>
<person name="Bisi J.E."/>
<person name="Kim M.K."/>
</authorList>
<dbReference type="PubMed" id="12402044"/>
<dbReference type="DOI" id="10.1038/ncb869"/>
</citation>
<scope>FUNCTION IN APOPTOSIS</scope>
<scope>FUNCTION IN PHOSPHORYLATION OF PML</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2002" name="Science" volume="298" first="1435" last="1438">
<title>53BP1, a mediator of the DNA damage checkpoint.</title>
<authorList>
<person name="Wang B."/>
<person name="Matsuoka S."/>
<person name="Carpenter P.B."/>
<person name="Elledge S.J."/>
</authorList>
<dbReference type="PubMed" id="12364621"/>
<dbReference type="DOI" id="10.1126/science.1076182"/>
</citation>
<scope>INTERACTION WITH TP53BP1</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="33134" last="33141">
<title>The promyelocytic leukemia protein protects p53 from Mdm2-mediated inhibition and degradation.</title>
<authorList>
<person name="Louria-Hayon I."/>
<person name="Grossman T."/>
<person name="Sionov R.V."/>
<person name="Alsheich O."/>
<person name="Pandolfi P.P."/>
<person name="Haupt Y."/>
</authorList>
<dbReference type="PubMed" id="12810724"/>
<dbReference type="DOI" id="10.1074/jbc.M301264200"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH PML AND TP53</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2003" name="Nat. Cell Biol." volume="5" first="401" last="409">
<title>Chk2 activates E2F-1 in response to DNA damage.</title>
<authorList>
<person name="Stevens C."/>
<person name="Smith L."/>
<person name="La Thangue N.B."/>
</authorList>
<dbReference type="PubMed" id="12717439"/>
<dbReference type="DOI" id="10.1038/ncb974"/>
</citation>
<scope>FUNCTION IN TRANSCRIPTION REGULATION</scope>
<scope>FUNCTION IN APOPTOSIS</scope>
<scope>FUNCTION IN PHOSPHORYLATION OF E2F1</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2003" name="Nature" volume="421" first="957" last="961">
<title>MDC1 is coupled to activated CHK2 in mammalian DNA damage response pathways.</title>
<authorList>
<person name="Lou Z."/>
<person name="Minter-Dykhouse K."/>
<person name="Wu X."/>
<person name="Chen J."/>
</authorList>
<dbReference type="PubMed" id="12607004"/>
<dbReference type="DOI" id="10.1038/nature01447"/>
</citation>
<scope>FUNCTION IN DNA DAMAGE RESPONSE</scope>
<scope>INTERACTION WITH MDC1</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2004" name="DNA Repair" volume="3" first="1039" last="1047">
<title>The Chk2 protein kinase.</title>
<authorList>
<person name="Ahn J."/>
<person name="Urist M."/>
<person name="Prives C."/>
</authorList>
<dbReference type="PubMed" id="15279791"/>
<dbReference type="DOI" id="10.1016/j.dnarep.2004.03.033"/>
</citation>
<scope>REVIEW ON PHOSPHORYLATION OF TP53 AND OTHER SUBSTRATES</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="47652" last="47660">
<title>The stress kinase MRK contributes to regulation of DNA damage checkpoints through a p38gamma-independent pathway.</title>
<authorList>
<person name="Tosti E."/>
<person name="Waldbaum L."/>
<person name="Warshaw G."/>
<person name="Gross E.A."/>
<person name="Ruggieri R."/>
</authorList>
<dbReference type="PubMed" id="15342622"/>
<dbReference type="DOI" id="10.1074/jbc.M409961200"/>
</citation>
<scope>ENZYME REGULATION</scope>
<scope>PHOSPHORYLATION AT THR-68 BY MAP3K20</scope>
<scope>MUTAGENESIS OF THR-68 AND ASP-368</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2005" name="EMBO J." volume="24" first="3411" last="3422">
<title>ATM and Chk2-dependent phosphorylation of MDMX contribute to p53 activation after DNA damage.</title>
<authorList>
<person name="Chen L."/>
<person name="Gilkes D.M."/>
<person name="Pan Y."/>
<person name="Lane W.S."/>
<person name="Chen J."/>
</authorList>
<dbReference type="PubMed" id="16163388"/>
<dbReference type="DOI" id="10.1038/sj.emboj.7600812"/>
</citation>
<scope>FUNCTION IN TP53 ACTIVATION</scope>
<scope>FUNCTION IN PHOSPHORYLATION OF MDM4</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2006" name="Cell Death Differ." volume="13" first="1170" last="1180">
<title>Regulation of the antioncogenic Chk2 kinase by the oncogenic Wip1 phosphatase.</title>
<authorList>
<person name="Fujimoto H."/>
<person name="Onishi N."/>
<person name="Kato N."/>
<person name="Takekawa M."/>
<person name="Xu X.Z."/>
<person name="Kosugi A."/>
<person name="Kondo T."/>
<person name="Imamura M."/>
<person name="Oishi I."/>
<person name="Yoda A."/>
<person name="Minami Y."/>
</authorList>
<dbReference type="PubMed" id="16311512"/>
<dbReference type="DOI" id="10.1038/sj.cdd.4401801"/>
</citation>
<scope>PHOSPHORYLATION AT THR-68</scope>
<scope>DEPHOSPHORYLATION AT THR-68 BY PPM1D</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2006" name="Mutat. Res." volume="596" first="166" last="176">
<title>Priming phosphorylation of Chk2 by polo-like kinase 3 (Plk3) mediates its full activation by ATM and a downstream checkpoint in response to DNA damage.</title>
<authorList>
<person name="Bahassi el M."/>
<person name="Myer D.L."/>
<person name="McKenney R.J."/>
<person name="Hennigan R.F."/>
<person name="Stambrook P.J."/>
</authorList>
<dbReference type="PubMed" id="16481012"/>
<dbReference type="DOI" id="10.1016/j.mrfmmm.2005.12.002"/>
</citation>
<scope>PHOSPHORYLATION AT SER-62; THR-68 AND SER-73</scope>
<scope>MUTAGENESIS OF SER-73</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2007" name="EMBO J." volume="26" first="2083" last="2093">
<title>Phosphorylation of pRB at Ser612 by Chk1/2 leads to a complex between pRB and E2F-1 after DNA damage.</title>
<authorList>
<person name="Inoue Y."/>
<person name="Kitagawa M."/>
<person name="Taya Y."/>
</authorList>
<dbReference type="PubMed" id="17380128"/>
<dbReference type="DOI" id="10.1038/sj.emboj.7601652"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF RB1</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2007" name="J. Biol. Chem." volume="282" first="30311" last="30321">
<title>Stability of checkpoint kinase 2 is regulated via phosphorylation at serine 456.</title>
<authorList>
<person name="Kass E.M."/>
<person name="Ahn J."/>
<person name="Tanaka T."/>
<person name="Freed-Pastor W.A."/>
<person name="Keezer S."/>
<person name="Prives C."/>
</authorList>
<dbReference type="PubMed" id="17715138"/>
<dbReference type="DOI" id="10.1074/jbc.M704642200"/>
</citation>
<scope>FUNCTION IN APOPTOSIS</scope>
<scope>PHOSPHORYLATION AT SER-456</scope>
<scope>UBIQUITINATION</scope>
<scope>MUTAGENESIS OF SER-456</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2007" name="Mol. Cell. Biol." volume="27" first="1007" last="1016">
<title>Chk2 mediates stabilization of the FoxM1 transcription factor to stimulate expression of DNA repair genes.</title>
<authorList>
<person name="Tan Y."/>
<person name="Raychaudhuri P."/>
<person name="Costa R.H."/>
</authorList>
<dbReference type="PubMed" id="17101782"/>
<dbReference type="DOI" id="10.1128/MCB.01068-06"/>
</citation>
<scope>FUNCTION IN DNA REPAIR</scope>
<scope>FUNCTION IN PHOSPHORYLATION OF FOXM1</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2008" name="Cell Cycle" volume="7" first="2705" last="2709">
<title>Nek6 is involved in G2/M phase cell cycle arrest through DNA damage-induced phosphorylation.</title>
<authorList>
<person name="Lee M.Y."/>
<person name="Kim H.J."/>
<person name="Kim M.A."/>
<person name="Jee H.J."/>
<person name="Kim A.J."/>
<person name="Bae Y.S."/>
<person name="Park J.I."/>
<person name="Chung J.H."/>
<person name="Yun J."/>
</authorList>
<dbReference type="PubMed" id="18728393"/>
<dbReference type="DOI" id="10.4161/cc.7.17.6551"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF NEK6</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2008" name="Mol. Cell. Biol." volume="28" first="5874" last="5885">
<title>Regulation of Chk2 ubiquitination and signaling through autophosphorylation of serine 379.</title>
<authorList>
<person name="Lovly C.M."/>
<person name="Yan L."/>
<person name="Ryan C.E."/>
<person name="Takada S."/>
<person name="Piwnica-Worms H."/>
</authorList>
<dbReference type="PubMed" id="18644861"/>
<dbReference type="DOI" id="10.1128/MCB.00821-08"/>
</citation>
<scope>FUNCTION IN APOPTOSIS</scope>
<scope>PHOSPHORYLATION AT SER-379</scope>
<scope>MUTAGENESIS OF SER-379</scope>
<scope>UBIQUITINATION</scope>
<scope>INTERACTION WITH CUL1</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2008" name="Oncogene" volume="27" first="3977" last="3985">
<title>The checkpoint kinases Chk1 and Chk2 regulate the functional associations between hBRCA2 and Rad51 in response to DNA damage.</title>
<authorList>
<person name="Bahassi E.M."/>
<person name="Ovesen J.L."/>
<person name="Riesenberg A.L."/>
<person name="Bernstein W.Z."/>
<person name="Hasty P.E."/>
<person name="Stambrook P.J."/>
</authorList>
<dbReference type="PubMed" id="18317453"/>
<dbReference type="DOI" id="10.1038/onc.2008.17"/>
</citation>
<scope>FUNCTION IN RAD51-MEDIATED DNA REPAIR</scope>
<scope>FUNCTION IN PHOSPHORYLATION OF BRCA2</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2009" name="Cell Cycle" volume="8" first="327" last="329">
<title>Polo-like kinase 4 phosphorylates Chk2.</title>
<authorList>
<person name="Petrinac S."/>
<person name="Ganuelas M.L."/>
<person name="Bonni S."/>
<person name="Nantais J."/>
<person name="Hudson J.W."/>
</authorList>
<dbReference type="PubMed" id="19164942"/>
<dbReference type="DOI" id="10.4161/cc.8.2.7355"/>
</citation>
<scope>PHOSPHORYLATION BY PLK4</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2010" name="Nat. Cell Biol." volume="12" first="492" last="499">
<title>The CHK2-BRCA1 tumour suppressor pathway ensures chromosomal stability in human somatic cells.</title>
<authorList>
<person name="Stolz A."/>
<person name="Ertych N."/>
<person name="Kienitz A."/>
<person name="Vogel C."/>
<person name="Schneider V."/>
<person name="Fritz B."/>
<person name="Jacob R."/>
<person name="Dittmar G."/>
<person name="Weichert W."/>
<person name="Petersen I."/>
<person name="Bastians H."/>
</authorList>
<dbReference type="PubMed" id="20364141"/>
<dbReference type="DOI" id="10.1038/ncb2051"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF BRCA1</scope>
<scope>FUNCTION IN CHROMOSOMAL STABILITY</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="39">
<citation type="journal article" date="2011" name="Hum. Mutat." volume="32" first="1000" last="1003">
<title>A recurrent CHEK2 p.H371Y mutation is associated with breast cancer risk in Chinese women.</title>
<authorList>
<person name="Liu Y."/>
<person name="Liao J."/>
<person name="Xu Y."/>
<person name="Chen W."/>
<person name="Liu D."/>
<person name="Ouyang T."/>
<person name="Li J."/>
<person name="Wang T."/>
<person name="Fan Z."/>
<person name="Fan T."/>
<person name="Lin B."/>
<person name="Xu X."/>
<person name="Xie Y."/>
</authorList>
<dbReference type="PubMed" id="21618645"/>
<dbReference type="DOI" id="10.1002/humu.21538"/>
</citation>
<scope>INVOLVEMENT IN SUSCEPTIBILITY TO BC</scope>
<scope>VARIANTS CYS-180 AND TYR-371</scope>
<scope>CHARACTERIZATION OF VARIANT TYR-371</scope>
</reference>
<reference key="40">
<citation type="journal article" date="2012" name="Nat. Struct. Mol. Biol." volume="19" first="201" last="206">
<title>The E3 ligase RNF8 regulates KU80 removal and NHEJ repair.</title>
<authorList>
<person name="Feng L."/>
<person name="Chen J."/>
</authorList>
<dbReference type="PubMed" id="22266820"/>
<dbReference type="DOI" id="10.1038/nsmb.2211"/>
</citation>
<scope>UBIQUITINATION BY RNF8</scope>
</reference>
<reference key="41">
<citation type="journal article" date="2014" name="Nucleic Acids Res." volume="42" first="13150" last="13160">
<title>Chk2 and REGgamma-dependent DBC1 regulation in DNA damage induced apoptosis.</title>
<authorList>
<person name="Magni M."/>
<person name="Ruscica V."/>
<person name="Buscemi G."/>
<person name="Kim J.E."/>
<person name="Nachimuthu B.T."/>
<person name="Fontanella E."/>
<person name="Delia D."/>
<person name="Zannini L."/>
</authorList>
<dbReference type="PubMed" id="25361978"/>
<dbReference type="DOI" id="10.1093/nar/gku1065"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH CCAR2 AND SIRT1</scope>
</reference>
<reference key="42">
<citation type="journal article" date="2002" name="Mol. Cell" volume="9" first="1045" last="1054">
<title>Structural and functional versatility of the FHA domain in DNA-damage signaling by the tumor suppressor kinase Chk2.</title>
<authorList>
<person name="Li J."/>
<person name="Williams B.L."/>
<person name="Haire L.F."/>
<person name="Goldberg M."/>
<person name="Wilker E."/>
<person name="Durocher D."/>
<person name="Yaffe M.B."/>
<person name="Jackson S.P."/>
<person name="Smerdon S.J."/>
</authorList>
<dbReference type="PubMed" id="12049740"/>
<dbReference type="DOI" id="10.1016/S1097-2765(02)00527-0"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS) OF 64-212</scope>
</reference>
<reference key="43">
<citation type="journal article" date="2006" name="EMBO J." volume="25" first="3179" last="3190">
<title>Trans-activation of the DNA-damage signalling protein kinase Chk2 by T-loop exchange.</title>
<authorList>
<person name="Oliver A.W."/>
<person name="Paul A."/>
<person name="Boxall K.J."/>
<person name="Barrie S.E."/>
<person name="Aherne G.W."/>
<person name="Garrett M.D."/>
<person name="Mittnacht S."/>
<person name="Pearl L.H."/>
</authorList>
<dbReference type="PubMed" id="16794575"/>
<dbReference type="DOI" id="10.1038/sj.emboj.7601209"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.25 ANGSTROMS) OF 210-531 IN COMPLEX WITH ADP AND INHIBITOR</scope>
<scope>HOMODIMERIZATION</scope>
<scope>AUTOPHOSPHORYLATION</scope>
</reference>
<reference key="44">
<citation type="journal article" date="2009" name="Mol. Cell" volume="35" first="818" last="829">
<title>Structure and activation mechanism of the CHK2 DNA damage checkpoint kinase.</title>
<authorList>
<person name="Cai Z."/>
<person name="Chehab N.H."/>
<person name="Pavletich N.P."/>
</authorList>
<dbReference type="PubMed" id="19782031"/>
<dbReference type="DOI" id="10.1016/j.molcel.2009.09.007"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (3.00 ANGSTROMS) OF 84-502 OF HOMODIMER</scope>
</reference>
<reference key="45">
<citation type="journal article" date="2014" name="J. Biol. Chem." volume="289" first="18258" last="18269">
<title>Collaborator of ARF (CARF) regulates proliferative fate of human cells by dose-dependent regulation of DNA damage signaling.</title>
<authorList>
<person name="Cheung C.T."/>
<person name="Singh R."/>
<person name="Kalra R.S."/>
<person name="Kaul S.C."/>
<person name="Wadhwa R."/>
</authorList>
<dbReference type="PubMed" id="24825908"/>
<dbReference type="DOI" id="10.1074/jbc.M114.547208"/>
</citation>
<scope>INTERACTION WITH CDKN2AIP</scope>
</reference>
<reference key="46">
<citation type="journal article" date="1999" name="Science" volume="286" first="2528" last="2531">
<title>Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome.</title>
<authorList>
<person name="Bell D.W."/>
<person name="Varley J.M."/>
<person name="Szydlo T.E."/>
<person name="Kang D.H."/>
<person name="Wahrer D.C.R."/>
<person name="Shannon K.E."/>
<person name="Lubratovich M."/>
<person name="Versalis S.J."/>
<person name="Isselbacher K.J."/>
<person name="Fraumeni J.F. Jr."/>
<person name="Birch J.M."/>
<person name="Li F.P."/>
<person name="Garber J.E."/>
<person name="Haber D.A."/>
</authorList>
<dbReference type="PubMed" id="10617473"/>
<dbReference type="DOI" id="10.1126/science.286.5449.2528"/>
</citation>
<scope>VARIANT THR-157</scope>
<scope>VARIANT COLON CANCER TRP-145</scope>
</reference>
<reference key="47">
<citation type="journal article" date="2001" name="Br. J. Cancer" volume="85" first="209" last="212">
<title>Mutation analysis of the CHK2 gene in families with hereditary breast cancer.</title>
<authorList>
<person name="Allinen M."/>
<person name="Huusko P."/>
<person name="Maentyniemi S."/>
<person name="Launonen V."/>
<person name="Winqvist R."/>
</authorList>
<dbReference type="PubMed" id="11461078"/>
<dbReference type="DOI" id="10.1054/bjoc.2001.1858"/>
</citation>
<scope>VARIANT THR-157</scope>
</reference>
<reference key="48">
<citation type="journal article" date="2001" name="Cancer Res." volume="61" first="8062" last="8067">
<title>Destabilization of CHK2 by a missense mutation associated with Li-Fraumeni Syndrome.</title>
<authorList>
<person name="Lee S.B."/>
<person name="Kim S.H."/>
<person name="Bell D.W."/>
<person name="Wahrer D.C.R."/>
<person name="Schiripo T.A."/>
<person name="Jorczak M.M."/>
<person name="Sgroi D.C."/>
<person name="Garber J.E."/>
<person name="Li F.P."/>
<person name="Nichols K.E."/>
<person name="Varley J.M."/>
<person name="Godwin A.K."/>
<person name="Shannon K.M."/>
<person name="Harlow E."/>
<person name="Haber D.A."/>
</authorList>
<dbReference type="PubMed" id="11719428"/>
</citation>
<scope>VARIANT LFS2 TRP-145</scope>
</reference>
<reference key="49">
<citation type="journal article" date="2002" name="Breast Cancer Res." volume="4" first="R4" last="R4">
<title>Mutation analysis of the CHK2 gene in breast carcinoma and other cancers.</title>
<authorList>
<person name="Ingvarsson S."/>
<person name="Sigbjornsdottir B.I."/>
<person name="Huiping C."/>
<person name="Hafsteinsdottir S.H."/>
<person name="Ragnarsson G."/>
<person name="Barkardottir R.B."/>
<person name="Arason A."/>
<person name="Egilsson V."/>
<person name="Bergthorsson J.T."/>
</authorList>
<dbReference type="PubMed" id="12052256"/>
<dbReference type="DOI" id="10.1186/bcr435"/>
</citation>
<scope>VARIANT MULTIPLE CANCERS LYS-59</scope>
</reference>
<reference key="50">
<citation type="journal article" date="2002" name="Br. J. Cancer" volume="87" first="1445" last="1448">
<title>CHEK2 variants in susceptibility to breast cancer and evidence of retention of the wild type allele in tumours.</title>
<authorList>
<person name="Sodha N."/>
<person name="Bullock S."/>
<person name="Taylor R."/>
<person name="Mitchell G."/>
<person name="Guertl-Lackner B."/>
<person name="Williams R.D."/>
<person name="Bevan S."/>
<person name="Bishop K."/>
<person name="McGuire S."/>
<person name="Houlston R.S."/>
<person name="Eeles R.A."/>
</authorList>
<dbReference type="PubMed" id="12454775"/>
<dbReference type="DOI" id="10.1038/sj.bjc.6600637"/>
</citation>
<scope>VARIANTS GLY-117; GLN-137 AND HIS-180</scope>
</reference>
<reference key="51">
<citation type="journal article" date="2002" name="Genes Chromosomes Cancer" volume="33" first="17" last="21">
<title>Mutations of the CHK2 gene are found in some osteosarcomas, but are rare in breast, lung, and ovarian tumors.</title>
<authorList>
<person name="Miller C.W."/>
<person name="Ikezoe T."/>
<person name="Krug U."/>
<person name="Hofmann W.K."/>
<person name="Tavor S."/>
<person name="Vegesna V."/>
<person name="Tsukasaki K."/>
<person name="Takeuchi S."/>
<person name="Koeffler H.P."/>
</authorList>
<dbReference type="PubMed" id="11746983"/>
<dbReference type="DOI" id="10.1002/gcc.1207"/>
</citation>
<scope>VARIANTS OSTEOSARCOMA SER-17 AND LEU-85</scope>
</reference>
<reference key="52">
<citation type="journal article" date="2003" name="Am. J. Hum. Genet." volume="72" first="270" last="280">
<title>Mutations in CHEK2 associated with prostate cancer risk.</title>
<authorList>
<person name="Dong X."/>
<person name="Wang L."/>
<person name="Taniguchi K."/>
<person name="Wang X."/>
<person name="Cunningham J.M."/>
<person name="McDonnell S.K."/>
<person name="Qian C."/>
<person name="Marks A.F."/>
<person name="Slager S.L."/>
<person name="Peterson B.J."/>
<person name="Smith D.I."/>
<person name="Cheville J.C."/>
<person name="Blute M.L."/>
<person name="Jacobsen S.J."/>
<person name="Schaid D.J."/>
<person name="Tindall D.J."/>
<person name="Thibodeau S.N."/>
<person name="Liu W."/>
</authorList>
<dbReference type="PubMed" id="12533788"/>
<dbReference type="DOI" id="10.1086/346094"/>
</citation>
<scope>VARIANTS PROSTATE CANCER LYS-64; PRO-145; ARG-167; CYS-180; HIS-180; CYS-181; HIS-181; LYS-239; PHE-251; HIS-318; PRO-323; CYS-327 AND LYS-476</scope>
<scope>VARIANT THR-157</scope>
</reference>
<reference key="53">
<citation type="journal article" date="2003" name="Am. J. Hum. Genet." volume="72" first="1023" last="1028">
<title>Variants in CHEK2 other than 1100delC do not make a major contribution to breast cancer susceptibility.</title>
<authorList>
<person name="Schutte M."/>
<person name="Seal S."/>
<person name="Barfoot R."/>
<person name="Meijers-Heijboer H."/>
<person name="Wasielewski M."/>
<person name="Evans D.G."/>
<person name="Eccles D."/>
<person name="Meijers C."/>
<person name="Lohman F."/>
<person name="Klijn J."/>
<person name="van den Ouweland A."/>
<person name="Brady A."/>
<person name="Cole T."/>
<person name="Collins A."/>
<person name="Cox H."/>
<person name="Donaldson A."/>
<person name="Eeles R."/>
<person name="Evans G."/>
<person name="Gregory H."/>
<person name="Gray J."/>
<person name="Houlston R."/>
<person name="Lalloo F."/>
<person name="Lucassen A."/>
<person name="Mackay J."/>
<person name="Mitchell G."/>
<person name="Morrison P."/>
<person name="Murday V."/>
<person name="Narod S."/>
<person name="Patterson J."/>
<person name="Peretz T."/>
<person name="Phelan C.M."/>
<person name="Rogers M."/>
<person name="Schofield A."/>
<person name="Tonin P."/>
<person name="Weber B."/>
<person name="Weber W."/>
<person name="Futreal P.A."/>
<person name="Nathanson K.L."/>
<person name="Weber B.L."/>
<person name="Easton D.F."/>
<person name="Stratton M.R."/>
<person name="Rahman N."/>
</authorList>
<dbReference type="PubMed" id="12610780"/>
<dbReference type="DOI" id="10.1086/373965"/>
</citation>
<scope>VARIANTS GLY-117; TRP-145 AND THR-157</scope>
</reference>
<reference key="54">
<citation type="journal article" date="2003" name="Br. J. Cancer" volume="89" first="1966" last="1970">
<title>CHEK2 variants associate with hereditary prostate cancer.</title>
<authorList>
<person name="Seppaelae E.H."/>
<person name="Ikonen T."/>
<person name="Mononen N."/>
<person name="Autio V."/>
<person name="Roekman A."/>
<person name="Matikainen M.P."/>
<person name="Tammela T.L.J."/>
<person name="Schleutker J."/>
</authorList>
<dbReference type="PubMed" id="14612911"/>
<dbReference type="DOI" id="10.1038/sj.bjc.6601425"/>
</citation>
<scope>VARIANT THR-157</scope>
</reference>
<reference key="55">
<citation type="journal article" date="2004" name="Am. J. Hum. Genet." volume="75" first="1131" last="1135">
<title>CHEK2 is a multiorgan cancer susceptibility gene.</title>
<authorList>
<person name="Cybulski C."/>
<person name="Gorski B."/>
<person name="Huzarski T."/>
<person name="Masojc B."/>
<person name="Mierzejewski M."/>
<person name="Debniak T."/>
<person name="Teodorczyk U."/>
<person name="Byrski T."/>
<person name="Gronwald J."/>
<person name="Matyjasik J."/>
<person name="Zlowocka E."/>
<person name="Lenner M."/>
<person name="Grabowska E."/>
<person name="Nej K."/>
<person name="Castaneda J."/>
<person name="Medrek K."/>
<person name="Szymanska A."/>
<person name="Szymanska J."/>
<person name="Kurzawski G."/>
<person name="Suchy J."/>
<person name="Oszurek O."/>
<person name="Witek A."/>
<person name="Narod S.A."/>
<person name="Lubinski J."/>
</authorList>
<dbReference type="PubMed" id="15492928"/>
<dbReference type="DOI" id="10.1086/426403"/>
</citation>
<scope>VARIANT THR-157</scope>
</reference>
<reference key="56">
<citation type="journal article" date="2004" name="Breast Cancer Res." volume="6" first="R629" last="R635">
<title>Frequency of CHEK2 mutations in a population based, case-control study of breast cancer in young women.</title>
<authorList>
<person name="Friedrichsen D.M."/>
<person name="Malone K.E."/>
<person name="Doody D.R."/>
<person name="Daling J.R."/>
<person name="Ostrander E.A."/>
</authorList>
<dbReference type="PubMed" id="15535844"/>
<dbReference type="DOI" id="10.1186/bcr933"/>
</citation>
<scope>VARIANTS TRP-145 AND THR-157</scope>
</reference>
<reference key="57">
<citation type="journal article" date="2004" name="Cancer Res." volume="64" first="2677" last="2679">
<title>A novel founder CHEK2 mutation is associated with increased prostate cancer risk.</title>
<authorList>
<person name="Cybulski C."/>
<person name="Huzarski T."/>
<person name="Gorski B."/>
<person name="Masojc B."/>
<person name="Mierzejewski M."/>
<person name="Debniak T."/>
<person name="Gliniewicz B."/>
<person name="Matyjasik J."/>
<person name="Zlowocka E."/>
<person name="Kurzawski G."/>
<person name="Sikorski A."/>
<person name="Posmyk M."/>
<person name="Szwiec M."/>
<person name="Czajka R."/>
<person name="Narod S.A."/>
<person name="Lubinski J."/>
</authorList>
<dbReference type="PubMed" id="15087378"/>
<dbReference type="DOI" id="10.1158/0008-5472.CAN-04-0341"/>
</citation>
<scope>VARIANT THR-157</scope>
</reference>
<reference key="58">
<citation type="journal article" date="2004" name="Int. J. Cancer" volume="110" first="320" last="325">
<title>Limited relevance of the CHEK2 gene in hereditary breast cancer.</title>
<authorList>
<person name="Dufault M.R."/>
<person name="Betz B."/>
<person name="Wappenschmidt B."/>
<person name="Hofmann W."/>
<person name="Bandick K."/>
<person name="Golla A."/>
<person name="Pietschmann A."/>
<person name="Nestle-Kraemling C."/>
<person name="Rhiem K."/>
<person name="Huettner C."/>
<person name="von Lindern C."/>
<person name="Dall P."/>
<person name="Kiechle M."/>
<person name="Untch M."/>
<person name="Jonat W."/>
<person name="Meindl A."/>
<person name="Scherneck S."/>
<person name="Niederacher D."/>
<person name="Schmutzler R.K."/>
<person name="Arnold N."/>
</authorList>
<dbReference type="PubMed" id="15095295"/>
<dbReference type="DOI" id="10.1002/ijc.20073"/>
</citation>
<scope>VARIANT THR-157</scope>
</reference>
<reference key="59">
<citation type="journal article" date="2004" name="Int. J. Cancer" volume="111" first="543" last="547">
<title>CHEK2 variant I157T may be associated with increased breast cancer risk.</title>
<authorList>
<person name="Kilpivaara O."/>
<person name="Vahteristo P."/>
<person name="Falck J."/>
<person name="Syrjaekoski K."/>
<person name="Eerola H."/>
<person name="Easton D."/>
<person name="Bartkova J."/>
<person name="Lukas J."/>
<person name="Heikkilae P."/>
<person name="Aittomaeki K."/>
<person name="Holli K."/>
<person name="Blomqvist C."/>
<person name="Kallioniemi O.-P."/>
<person name="Bartek J."/>
<person name="Nevanlinna H."/>
</authorList>
<dbReference type="PubMed" id="15239132"/>
<dbReference type="DOI" id="10.1002/ijc.20299"/>
</citation>
<scope>VARIANT THR-157</scope>
</reference>
<reference key="60">
<citation type="journal article" date="2005" name="Hum. Mol. Genet." volume="14" first="555" last="563">
<title>Functional and genomic approaches reveal an ancient CHEK2 allele associated with breast cancer in the Ashkenazi Jewish population.</title>
<authorList>
<person name="Shaag A."/>
<person name="Walsh T."/>
<person name="Renbaum P."/>
<person name="Kirchhoff T."/>
<person name="Nafa K."/>
<person name="Shiovitz S."/>
<person name="Mandell J.B."/>
<person name="Welcsh P."/>
<person name="Lee M.K."/>
<person name="Ellis N."/>
<person name="Offit K."/>
<person name="Levy-Lahad E."/>
<person name="King M.-C."/>
</authorList>
<dbReference type="PubMed" id="15649950"/>
<dbReference type="DOI" id="10.1093/hmg/ddi052"/>
</citation>
<scope>VARIANTS LEU-85 AND PHE-428</scope>
</reference>
<reference key="61">
<citation type="journal article" date="2005" name="Int. J. Cancer" volume="116" first="263" last="266">
<title>Association of two mutations in the CHEK2 gene with breast cancer.</title>
<authorList>
<person name="Bogdanova N."/>
<person name="Enbetaen-Dubrowinskaja N."/>
<person name="Feshchenko S."/>
<person name="Lazjuk G.I."/>
<person name="Rogov Y.I."/>
<person name="Dammann O."/>
<person name="Bremer M."/>
<person name="Karstens J.H."/>
<person name="Sohn C."/>
<person name="Doerk T."/>
</authorList>
<dbReference type="PubMed" id="15810020"/>
<dbReference type="DOI" id="10.1002/ijc.21022"/>
</citation>
<scope>VARIANT THR-157</scope>
</reference>
<reference key="62">
<citation type="journal article" date="2005" name="J. Pathol." volume="206" first="198" last="204">
<title>Homozygosity for a CHEK2*1100delC mutation identified in familial colorectal cancer does not lead to a severe clinical phenotype.</title>
<authorList>
<person name="van Puijenbroek M."/>
<person name="van Asperen C.J."/>
<person name="van Mil A."/>
<person name="Devilee P."/>
<person name="van Wezel T."/>
<person name="Morreau H."/>
</authorList>
<dbReference type="PubMed" id="15818573"/>
<dbReference type="DOI" id="10.1002/path.1764"/>
</citation>
<scope>VARIANTS GLY-117; GLN-137; TRP-145; THR-157 AND HIS-180</scope>
</reference>
<reference key="63">
<citation type="journal article" date="2015" name="Oncogene" volume="34" first="5198" last="5205">
<title>A novel recurrent CHEK2 Y390C mutation identified in high-risk Chinese breast cancer patients impairs its activity and is associated with increased breast cancer risk.</title>
<authorList>
<person name="Wang N."/>
<person name="Ding H."/>
<person name="Liu C."/>
<person name="Li X."/>
<person name="Wei L."/>
<person name="Yu J."/>
<person name="Liu M."/>
<person name="Ying M."/>
<person name="Gao W."/>
<person name="Jiang H."/>
<person name="Wang Y."/>
</authorList>
<dbReference type="PubMed" id="25619829"/>
<dbReference type="DOI" id="10.1038/onc.2014.443"/>
</citation>
<scope>VARIANT BC CYS-390</scope>
<scope>CHARACTERIZATION OF VARIANT BC CYS-390</scope>
<scope>FUNCTION</scope>
</reference>
<comment type="function">
<text evidence="9 12 14 16 25 28 30 31 42 46 47 48 49 50 51 53 56 57 58 59">Serine/threonine-protein kinase which is required for checkpoint-mediated cell cycle arrest, activation of DNA repair and apoptosis in response to the presence of DNA double-strand breaks. May also negatively regulate cell cycle progression during unperturbed cell cycles. Following activation, phosphorylates numerous effectors preferentially at the consensus sequence [L-X-R-X-X-S/T]. Regulates cell cycle checkpoint arrest through phosphorylation of CDC25A, CDC25B and CDC25C, inhibiting their activity. Inhibition of CDC25 phosphatase activity leads to increased inhibitory tyrosine phosphorylation of CDK-cyclin complexes and blocks cell cycle progression. May also phosphorylate NEK6 which is involved in G2/M cell cycle arrest. Regulates DNA repair through phosphorylation of BRCA2, enhancing the association of RAD51 with chromatin which promotes DNA repair by homologous recombination. Also stimulates the transcription of genes involved in DNA repair (including BRCA2) through the phosphorylation and activation of the transcription factor FOXM1. Regulates apoptosis through the phosphorylation of p53/TP53, MDM4 and PML. Phosphorylation of p53/TP53 at 'Ser-20' by CHEK2 may alleviate inhibition by MDM2, leading to accumulation of active p53/TP53. Phosphorylation of MDM4 may also reduce degradation of p53/TP53. Also controls the transcription of pro-apoptotic genes through phosphorylation of the transcription factor E2F1. Tumor suppressor, it may also have a DNA damage-independent function in mitotic spindle assembly by phosphorylating BRCA1. Its absence may be a cause of the chromosomal instability observed in some cancer cells. Promotes the CCAR2-SIRT1 association and is required for CCAR2-mediated SIRT1 inhibition (PubMed:25361978).</text>
</comment>
<comment type="catalytic activity">
<text>ATP + a protein = ADP + a phosphoprotein.</text>
</comment>
<comment type="cofactor">
<cofactor>
<name>Mg(2+)</name>
<dbReference type="ChEBI" id="CHEBI:18420"/>
</cofactor>
</comment>
<comment type="enzyme regulation">
<text evidence="36">Activated through phosphorylation at Thr-68 by ATM in response to DNA double-strand breaks. Activation is modulated by several mediators including MDC1 and TP53BP1. Induces homodimerization with exchange of the T-loop/activation segment between protomers and transphosphorylation of the protomers. The autophosphorylated kinase dimer is fully active. Negatively regulated by PPM1D through dephosphorylation of Thr-68.</text>
</comment>
<comment type="subunit">
<text evidence="14 16 24 28 31 45 50 55 56">Homodimer. Homodimerization is part of the activation process but the dimer may dissociate following activation. Interacts with PML. Interacts with TP53. Interacts with RB1; phosphorylates RB1. Interacts with BRCA1. Interacts (phosphorylated at Thr-68) with MDC1; requires ATM-mediated phosphorylation of CHEK2. Interacts with TP53BP1; modulates CHEK2 phosphorylation at Thr-68 in response to ionizing radiation. Interacts with CDC25A; phosphorylates CDC25A and mediates its degradation in response to ionizing radiation. Interacts with CUL1; mediates CHEK2 ubiquitination and regulation. Interacts with CDKN2AIP. Interacts (via protein kinase domain) with CCAR2 (via N-terminus). Interacts with SIRT1.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1180783"/>
<interactant intactId="EBI-1180783"/>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1180783"/>
<interactant intactId="EBI-6904388">
<id>P27958</id>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1180783"/>
<interactant intactId="EBI-372428">
<id>Q9NY61</id>
<label>AATF</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1180783"/>
<interactant intactId="EBI-11579223">
<id>Q9UQ88-1</id>
<label>CDK11A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1180783"/>
<interactant intactId="EBI-9057780">
<id>Q96KN1</id>
<label>FAM84B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1180783"/>
<interactant intactId="EBI-747491">
<id>Q9Y248</id>
<label>GINS2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1180783"/>
<interactant intactId="EBI-3915542">
<id>Q13007</id>
<label>IL24</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1180783"/>
<interactant intactId="EBI-2827813">
<id>P56645</id>
<label>PER3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1180783"/>
<interactant intactId="EBI-476768">
<id>P53350</id>
<label>PLK1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1180783"/>
<interactant intactId="EBI-641666">
<id>Q15172</id>
<label>PPP2R5A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1180783"/>
<interactant intactId="EBI-1369497">
<id>Q15173</id>
<label>PPP2R5B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1180783"/>
<interactant intactId="EBI-1266170">
<id>Q13362-1</id>
<label>PPP2R5C</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1180783"/>
<interactant intactId="EBI-1266173">
<id>Q13362-2</id>
<label>PPP2R5C</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1180783"/>
<interactant intactId="EBI-1266176">
<id>Q13362-3</id>
<label>PPP2R5C</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1180783"/>
<interactant intactId="EBI-968374">
<id>Q16537</id>
<label>PPP2R5E</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1180783"/>
<interactant intactId="EBI-491274">
<id>P06400</id>
<label>RB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1180783"/>
<interactant intactId="EBI-2372238">
<id>Q5VTR2</id>
<label>RNF20</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1180783"/>
<interactant intactId="EBI-355164">
<id>P55072</id>
<label>VCP</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1180783"/>
<interactant intactId="EBI-947466">
<id>P18887</id>
<label>XRCC1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="subcellular location">
<molecule>Isoform 2</molecule>
<subcellularLocation>
<location>Nucleus</location>
</subcellularLocation>
<text>Isoform 10 is present throughout the cell.</text>
</comment>
<comment type="subcellular location">
<molecule>Isoform 4</molecule>
<subcellularLocation>
<location>Nucleus</location>
</subcellularLocation>
</comment>
<comment type="subcellular location">
<molecule>Isoform 7</molecule>
<subcellularLocation>
<location>Nucleus</location>
</subcellularLocation>
</comment>
<comment type="subcellular location">
<molecule>Isoform 9</molecule>
<subcellularLocation>
<location>Nucleus</location>
</subcellularLocation>
</comment>
<comment type="subcellular location">
<molecule>Isoform 12</molecule>
<subcellularLocation>
<location>Nucleus</location>
</subcellularLocation>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Nucleus</location>
<location>PML body</location>
</subcellularLocation>
<subcellularLocation>
<location>Nucleus</location>
<location>Nucleoplasm</location>
</subcellularLocation>
<text>Recruited into PML bodies together with TP53.</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>O96017-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>O96017-2</id>
<name>2</name>
<name>ins2</name>
<sequence type="described" ref="VSP_014564 VSP_014567 VSP_014568"/>
<text>Lacks enzymatic activity.</text>
</isoform>
<isoform>
<id>O96017-3</id>
<name>3</name>
<name>del2-12</name>
<sequence type="described" ref="VSP_014559"/>
</isoform>
<isoform>
<id>O96017-4</id>
<name>4</name>
<name>del2-3</name>
<sequence type="described" ref="VSP_014558"/>
<text>Lacks enzymatic activity.</text>
</isoform>
<isoform>
<id>O96017-5</id>
<name>5</name>
<name>del4</name>
<sequence type="described" ref="VSP_014565 VSP_014566"/>
</isoform>
<isoform>
<id>O96017-6</id>
<name>6</name>
<name>sub3</name>
<sequence type="described" ref="VSP_014562 VSP_014563"/>
</isoform>
<isoform>
<id>O96017-7</id>
<name>7</name>
<name>del9-12</name>
<sequence type="described" ref="VSP_014572 VSP_014573"/>
<text>Lacks enzymatic activity.</text>
</isoform>
<isoform>
<id>O96017-8</id>
<name>8</name>
<name>del7</name>
<sequence type="described" ref="VSP_014569 VSP_014570"/>
</isoform>
<isoform>
<id>O96017-9</id>
<name>9</name>
<name>insx</name>
<sequence type="described" ref="VSP_014557"/>
<text>Retains low level of catalytic activity.</text>
</isoform>
<isoform>
<id>O96017-10</id>
<name>10</name>
<name>iso2</name>
<sequence type="described" ref="VSP_014560 VSP_014561"/>
<text>Lacks enzymatic activity.</text>
</isoform>
<isoform>
<id>O96017-11</id>
<name>11</name>
<name>iso1</name>
<sequence type="described" ref="VSP_014556"/>
</isoform>
<isoform>
<id>O96017-12</id>
<name>12</name>
<name>del9</name>
<sequence type="described" ref="VSP_014571"/>
<text>Lacks enzymatic activity.</text>
</isoform>
<isoform>
<id>O96017-13</id>
<name>13</name>
<sequence type="described" ref="VSP_045148"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text>High expression is found in testis, spleen, colon and peripheral blood leukocytes. Low expression is found in other tissues.</text>
</comment>
<comment type="PTM">
<text evidence="15 17 36 43 44 48 50 52">Phosphorylated. Phosphorylated at Ser-73 by PLK3 in response to DNA damage, promoting phosphorylation at Thr-68 by ATM and the G2/M transition checkpoint. Phosphorylation at Thr-68 induces homodimerization. Autophosphorylates at Thr-383 and Thr-387 in the T-loop/activation segment upon dimerization to become fully active and phosphorylate its substrates like for instance CDC25C. DNA damage-induced autophosphorylation at Ser-379 induces CUL1-mediated ubiquitination and regulates the pro-apoptotic function. Phosphorylation at Ser-456 also regulates ubiquitination. Phosphorylated by PLK4.</text>
</comment>
<comment type="PTM">
<text>Ubiquitinated. CUL1-mediated ubiquitination regulates the pro-apoptotic function. Ubiquitination may also regulate protein stability. Ubiquitinated by RNF8 via 'Lys-48'-linked ubiquitination.</text>
</comment>
<comment type="disease" evidence="19">
<disease id="DI-02882">
<name>Li-Fraumeni syndrome 2</name>
<acronym>LFS2</acronym>
<description>A highly penetrant familial cancer syndrome that in its classic form is defined by the existence of a proband affected by a sarcoma before 45 years with a first degree relative affected by any tumor before 45 years and another first degree relative with any tumor before 45 years or a sarcoma at any age. Other clinical definitions for LFS have been proposed (PubMed:8118819 and PubMed:8718514) and called Li-Fraumeni like syndrome (LFL). In these families affected relatives develop a diverse set of malignancies at unusually early ages. Four types of cancers account for 80% of tumors occurring in TP53 germline mutation carriers: breast cancers, soft tissue and bone sarcomas, brain tumors (astrocytomas) and adrenocortical carcinomas. Less frequent tumors include choroid plexus carcinoma or papilloma before the age of 15, rhabdomyosarcoma before the age of 5, leukemia, Wilms tumor, malignant phyllodes tumor, colorectal and gastric cancers.</description>
<dbReference type="MIM" id="609265"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="27">
<disease id="DI-02663">
<name>Prostate cancer</name>
<acronym>PC</acronym>
<description>A malignancy originating in tissues of the prostate. Most prostate cancers are adenocarcinomas that develop in the acini of the prostatic ducts. Other rare histopathologic types of prostate cancer that occur in approximately 5% of patients include small cell carcinoma, mucinous carcinoma, prostatic ductal carcinoma, transitional cell carcinoma, squamous cell carcinoma, basal cell carcinoma, adenoid cystic carcinoma (basaloid), signet-ring cell carcinoma and neuroendocrine carcinoma.</description>
<dbReference type="MIM" id="176807"/>
</disease>
<text>Disease susceptibility is associated with variations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease">
<disease id="DI-02109">
<name>Osteogenic sarcoma</name>
<acronym>OSRC</acronym>
<description>A sarcoma originating in bone-forming cells, affecting the ends of long bones.</description>
<dbReference type="MIM" id="259500"/>
</disease>
<text>The gene represented in this entry may be involved in disease pathogenesis.</text>
</comment>
<comment type="disease" evidence="23 54 57">
<disease id="DI-02602">
<name>Breast cancer</name>
<acronym>BC</acronym>
<description>A common malignancy originating from breast epithelial tissue. Breast neoplasms can be distinguished by their histologic pattern. Invasive ductal carcinoma is by far the most common type. Breast cancer is etiologically and genetically heterogeneous. Important genetic factors have been indicated by familial occurrence and bilateral involvement. Mutations at more than one locus can be involved in different families or even in the same case.</description>
<dbReference type="MIM" id="114480"/>
</disease>
<text evidence="23">Disease susceptibility is associated with variations affecting the gene represented in this entry.</text>
</comment>
<comment type="similarity">
<text evidence="66">Belongs to the protein kinase superfamily. CAMK Ser/Thr protein kinase family. CHK2 subfamily.</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/CHEK2ID312.html"/>
</comment>
<comment type="online information" name="NIEHS-SNPs">
<link uri="http://egp.gs.washington.edu/data/chek2/"/>
</comment>
<dbReference type="EC" id="2.7.11.1"/>
<dbReference type="EMBL" id="AF086904">
<property type="protein sequence ID" value="AAC83693.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AJ131197">
<property type="protein sequence ID" value="CAA10319.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF096279">
<property type="protein sequence ID" value="AAD11784.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY551295">
<property type="protein sequence ID" value="AAS58456.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY551296">
<property type="protein sequence ID" value="AAS58457.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY551297">
<property type="protein sequence ID" value="AAS58458.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY551298">
<property type="protein sequence ID" value="AAS58459.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY551299">
<property type="protein sequence ID" value="AAS58460.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY551300">
<property type="protein sequence ID" value="AAS58461.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY551301">
<property type="protein sequence ID" value="AAS58462.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY551302">
<property type="protein sequence ID" value="AAS58463.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY551303">
<property type="protein sequence ID" value="AAS58464.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY551304">
<property type="protein sequence ID" value="AAS58465.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY551305">
<property type="protein sequence ID" value="AAS58466.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="CR456418">
<property type="protein sequence ID" value="CAG30304.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF174135">
<property type="protein sequence ID" value="AAD48504.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB040105">
<property type="protein sequence ID" value="BAB17231.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK290754">
<property type="protein sequence ID" value="BAF83443.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF217975">
<property type="protein sequence ID" value="AAG17218.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY800241">
<property type="protein sequence ID" value="AAV41895.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL121825">
<property type="protein sequence ID" value="CAH73823.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL117330">
<property type="protein sequence ID" value="CAH73823.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL117330">
<property type="protein sequence ID" value="CAH73875.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL121825">
<property type="protein sequence ID" value="CAH73875.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL121825">
<property type="protein sequence ID" value="CAX11957.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL117330">
<property type="protein sequence ID" value="CAX11957.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL121825">
<property type="protein sequence ID" value="CAX11958.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL117330">
<property type="protein sequence ID" value="CAX11958.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL121825">
<property type="protein sequence ID" value="CAX11959.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL117330">
<property type="protein sequence ID" value="CAX11959.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL117330">
<property type="protein sequence ID" value="CAX14026.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL121825">
<property type="protein sequence ID" value="CAX14026.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL117330">
<property type="protein sequence ID" value="CAX14027.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL121825">
<property type="protein sequence ID" value="CAX14027.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL117330">
<property type="protein sequence ID" value="CAX14028.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL121825">
<property type="protein sequence ID" value="CAX14028.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471095">
<property type="protein sequence ID" value="EAW59755.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC004207">
<property type="protein sequence ID" value="AAH04207.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS13843.1">
<molecule id="O96017-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS13844.1">
<molecule id="O96017-12"/>
</dbReference>
<dbReference type="CCDS" id="CCDS33629.1">
<molecule id="O96017-9"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001005735.1">
<molecule id="O96017-9"/>
<property type="nucleotide sequence ID" value="NM_001005735.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001244316.1">
<molecule id="O96017-13"/>
<property type="nucleotide sequence ID" value="NM_001257387.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_009125.1">
<molecule id="O96017-1"/>
<property type="nucleotide sequence ID" value="NM_007194.3"/>
</dbReference>
<dbReference type="RefSeq" id="NP_665861.1">
<molecule id="O96017-12"/>
<property type="nucleotide sequence ID" value="NM_145862.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011528147.1">
<molecule id="O96017-13"/>
<property type="nucleotide sequence ID" value="XM_011529845.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_016884050.1">
<molecule id="O96017-13"/>
<property type="nucleotide sequence ID" value="XM_017028561.1"/>
</dbReference>
<dbReference type="UniGene" id="Hs.291363"/>
<dbReference type="UniGene" id="Hs.505297"/>
<dbReference type="PDB" id="1GXC">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="A/D/G/J=64-212"/>
</dbReference>
<dbReference type="PDB" id="2CN5">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.25"/>
<property type="chains" value="A=210-531"/>
</dbReference>
<dbReference type="PDB" id="2CN8">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="A=210-531"/>
</dbReference>
<dbReference type="PDB" id="2W0J">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.05"/>
<property type="chains" value="A=210-531"/>
</dbReference>
<dbReference type="PDB" id="2W7X">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.07"/>
<property type="chains" value="A=210-531"/>
</dbReference>
<dbReference type="PDB" id="2WTC">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.00"/>
<property type="chains" value="A=210-531"/>
</dbReference>
<dbReference type="PDB" id="2WTD">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.75"/>
<property type="chains" value="A=210-531"/>
</dbReference>
<dbReference type="PDB" id="2WTI">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A=210-531"/>
</dbReference>
<dbReference type="PDB" id="2WTJ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A=210-531"/>
</dbReference>
<dbReference type="PDB" id="2XBJ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A=210-531"/>
</dbReference>
<dbReference type="PDB" id="2XK9">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.35"/>
<property type="chains" value="A=210-531"/>
</dbReference>
<dbReference type="PDB" id="2XM8">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.40"/>
<property type="chains" value="A=210-531"/>
</dbReference>
<dbReference type="PDB" id="2XM9">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A=210-531"/>
</dbReference>
<dbReference type="PDB" id="2YCF">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.77"/>
<property type="chains" value="A=210-530"/>
</dbReference>
<dbReference type="PDB" id="2YCQ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.05"/>
<property type="chains" value="A=210-531"/>
</dbReference>
<dbReference type="PDB" id="2YCR">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A=210-531"/>
</dbReference>
<dbReference type="PDB" id="2YCS">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.35"/>
<property type="chains" value="A=210-531"/>
</dbReference>
<dbReference type="PDB" id="2YIQ">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.89"/>
<property type="chains" value="A=210-531"/>
</dbReference>
<dbReference type="PDB" id="2YIR">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A=210-531"/>
</dbReference>
<dbReference type="PDB" id="2YIT">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A=210-531"/>
</dbReference>
<dbReference type="PDB" id="3I6U">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.00"/>
<property type="chains" value="A/B=84-502"/>
</dbReference>
<dbReference type="PDB" id="3I6W">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.25"/>
<property type="chains" value="A/B/C/D/E/F/G/H=70-512"/>
</dbReference>
<dbReference type="PDB" id="3VA4">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.54"/>
<property type="chains" value="C=63-73"/>
</dbReference>
<dbReference type="PDB" id="4A9R">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.85"/>
<property type="chains" value="A=210-531"/>
</dbReference>
<dbReference type="PDB" id="4A9S">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.66"/>
<property type="chains" value="A=210-531"/>
</dbReference>
<dbReference type="PDB" id="4A9T">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="A=210-531"/>
</dbReference>
<dbReference type="PDB" id="4A9U">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.48"/>
<property type="chains" value="A=210-531"/>
</dbReference>
<dbReference type="PDB" id="4BDA">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="A=210-531"/>
</dbReference>
<dbReference type="PDB" id="4BDB">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A=210-531"/>
</dbReference>
<dbReference type="PDB" id="4BDC">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.00"/>
<property type="chains" value="A=210-531"/>
</dbReference>
<dbReference type="PDB" id="4BDD">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.67"/>
<property type="chains" value="A=210-531"/>
</dbReference>
<dbReference type="PDB" id="4BDE">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.55"/>
<property type="chains" value="A=210-531"/>
</dbReference>
<dbReference type="PDB" id="4BDF">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="A=210-531"/>
</dbReference>
<dbReference type="PDB" id="4BDG">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.84"/>
<property type="chains" value="A=210-531"/>
</dbReference>
<dbReference type="PDB" id="4BDH">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="A=210-531"/>
</dbReference>
<dbReference type="PDB" id="4BDI">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.32"/>
<property type="chains" value="A=210-531"/>
</dbReference>
<dbReference type="PDB" id="4BDJ">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.01"/>
<property type="chains" value="A=210-531"/>
</dbReference>
<dbReference type="PDB" id="4BDK">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.30"/>
<property type="chains" value="A=210-531"/>
</dbReference>
<dbReference type="PDBsum" id="1GXC"/>
<dbReference type="PDBsum" id="2CN5"/>
<dbReference type="PDBsum" id="2CN8"/>
<dbReference type="PDBsum" id="2W0J"/>
<dbReference type="PDBsum" id="2W7X"/>
<dbReference type="PDBsum" id="2WTC"/>
<dbReference type="PDBsum" id="2WTD"/>
<dbReference type="PDBsum" id="2WTI"/>
<dbReference type="PDBsum" id="2WTJ"/>
<dbReference type="PDBsum" id="2XBJ"/>
<dbReference type="PDBsum" id="2XK9"/>
<dbReference type="PDBsum" id="2XM8"/>
<dbReference type="PDBsum" id="2XM9"/>
<dbReference type="PDBsum" id="2YCF"/>
<dbReference type="PDBsum" id="2YCQ"/>
<dbReference type="PDBsum" id="2YCR"/>
<dbReference type="PDBsum" id="2YCS"/>
<dbReference type="PDBsum" id="2YIQ"/>
<dbReference type="PDBsum" id="2YIR"/>
<dbReference type="PDBsum" id="2YIT"/>
<dbReference type="PDBsum" id="3I6U"/>
<dbReference type="PDBsum" id="3I6W"/>
<dbReference type="PDBsum" id="3VA4"/>
<dbReference type="PDBsum" id="4A9R"/>
<dbReference type="PDBsum" id="4A9S"/>
<dbReference type="PDBsum" id="4A9T"/>
<dbReference type="PDBsum" id="4A9U"/>
<dbReference type="PDBsum" id="4BDA"/>
<dbReference type="PDBsum" id="4BDB"/>
<dbReference type="PDBsum" id="4BDC"/>
<dbReference type="PDBsum" id="4BDD"/>
<dbReference type="PDBsum" id="4BDE"/>
<dbReference type="PDBsum" id="4BDF"/>
<dbReference type="PDBsum" id="4BDG"/>
<dbReference type="PDBsum" id="4BDH"/>
<dbReference type="PDBsum" id="4BDI"/>
<dbReference type="PDBsum" id="4BDJ"/>
<dbReference type="PDBsum" id="4BDK"/>
<dbReference type="ProteinModelPortal" id="O96017"/>
<dbReference type="SMR" id="O96017"/>
<dbReference type="BioGrid" id="116369">
<property type="interactions" value="95"/>
</dbReference>
<dbReference type="DIP" id="DIP-24270N"/>
<dbReference type="IntAct" id="O96017">
<property type="interactions" value="106"/>
</dbReference>
<dbReference type="MINT" id="MINT-124588"/>
<dbReference type="BindingDB" id="O96017"/>
<dbReference type="ChEMBL" id="CHEMBL2527"/>
<dbReference type="DrugBank" id="DB05149">
<property type="generic name" value="XL844"/>
</dbReference>
<dbReference type="GuidetoPHARMACOLOGY" id="1988"/>
<dbReference type="iPTMnet" id="O96017"/>
<dbReference type="PhosphoSitePlus" id="O96017"/>
<dbReference type="BioMuta" id="CHEK2"/>
<dbReference type="EPD" id="O96017"/>
<dbReference type="MaxQB" id="O96017"/>
<dbReference type="PeptideAtlas" id="O96017"/>
<dbReference type="PRIDE" id="O96017"/>
<dbReference type="DNASU" id="11200"/>
<dbReference type="Ensembl" id="ENST00000328354">
<molecule id="O96017-1"/>
<property type="protein sequence ID" value="ENSP00000329178"/>
<property type="gene ID" value="ENSG00000183765"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000348295">
<molecule id="O96017-12"/>
<property type="protein sequence ID" value="ENSP00000329012"/>
<property type="gene ID" value="ENSG00000183765"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000382580">
<molecule id="O96017-9"/>
<property type="protein sequence ID" value="ENSP00000372023"/>
<property type="gene ID" value="ENSG00000183765"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000402731">
<molecule id="O96017-12"/>
<property type="protein sequence ID" value="ENSP00000384835"/>
<property type="gene ID" value="ENSG00000183765"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000403642">
<molecule id="O96017-4"/>
<property type="protein sequence ID" value="ENSP00000384919"/>
<property type="gene ID" value="ENSG00000183765"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000404276">
<molecule id="O96017-1"/>
<property type="protein sequence ID" value="ENSP00000385747"/>
<property type="gene ID" value="ENSG00000183765"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000405598">
<molecule id="O96017-1"/>
<property type="protein sequence ID" value="ENSP00000386087"/>
<property type="gene ID" value="ENSG00000183765"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000417588">
<molecule id="O96017-5"/>
<property type="protein sequence ID" value="ENSP00000412901"/>
<property type="gene ID" value="ENSG00000183765"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000433728">
<molecule id="O96017-8"/>
<property type="protein sequence ID" value="ENSP00000404400"/>
<property type="gene ID" value="ENSG00000183765"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000448511">
<molecule id="O96017-6"/>
<property type="protein sequence ID" value="ENSP00000404567"/>
<property type="gene ID" value="ENSG00000183765"/>
</dbReference>
<dbReference type="GeneID" id="11200"/>
<dbReference type="KEGG" id="hsa:11200"/>
<dbReference type="UCSC" id="uc003adt.2">
<molecule id="O96017-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="11200"/>
<dbReference type="DisGeNET" id="11200"/>
<dbReference type="GeneCards" id="CHEK2"/>
<dbReference type="HGNC" id="HGNC:16627">
<property type="gene designation" value="CHEK2"/>
</dbReference>
<dbReference type="HPA" id="CAB002030"/>
<dbReference type="HPA" id="HPA001878"/>
<dbReference type="MalaCards" id="CHEK2"/>
<dbReference type="MIM" id="114480">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="176807">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="259500">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="604373">
<property type="type" value="gene+phenotype"/>
</dbReference>
<dbReference type="MIM" id="609265">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_O96017"/>
<dbReference type="OpenTargets" id="ENSG00000183765"/>
<dbReference type="Orphanet" id="1331">
<property type="disease" value="Familial prostate cancer"/>
</dbReference>
<dbReference type="Orphanet" id="145">
<property type="disease" value="Hereditary breast and ovarian cancer syndrome"/>
</dbReference>
<dbReference type="Orphanet" id="524">
<property type="disease" value="Li-Fraumeni syndrome"/>
</dbReference>
<dbReference type="Orphanet" id="668">
<property type="disease" value="Osteosarcoma"/>
</dbReference>
<dbReference type="PharmGKB" id="PA404"/>
<dbReference type="GeneTree" id="ENSGT00800000124190"/>
<dbReference type="HOGENOM" id="HOG000233016"/>
<dbReference type="HOVERGEN" id="HBG108055"/>
<dbReference type="InParanoid" id="O96017"/>
<dbReference type="KO" id="K06641"/>
<dbReference type="OMA" id="SRAVDCW"/>
<dbReference type="OrthoDB" id="EOG091G0DVW"/>
<dbReference type="PhylomeDB" id="O96017"/>
<dbReference type="TreeFam" id="TF101082"/>
<dbReference type="BRENDA" id="2.7.11.1">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5693565">
<property type="pathway name" value="Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6804756">
<property type="pathway name" value="Regulation of TP53 Activity through Phosphorylation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6804757">
<property type="pathway name" value="Regulation of TP53 Degradation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6804760">
<property type="pathway name" value="Regulation of TP53 Activity through Methylation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-69473">
<property type="pathway name" value="G2/M DNA damage checkpoint"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-69541">
<property type="pathway name" value="Stabilization of p53"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-69601">
<property type="pathway name" value="Ubiquitin Mediated Degradation of Phosphorylated Cdc25A"/>
</dbReference>
<dbReference type="SignaLink" id="O96017"/>
<dbReference type="SIGNOR" id="O96017"/>
<dbReference type="EvolutionaryTrace" id="O96017"/>
<dbReference type="GeneWiki" id="CHEK2"/>
<dbReference type="GenomeRNAi" id="11200"/>
<dbReference type="PRO" id="PR:O96017"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 22"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000183765"/>
<dbReference type="ExpressionAtlas" id="O96017">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="O96017">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005794">
<property type="term" value="C:Golgi apparatus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0016605">
<property type="term" value="C:PML body"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0042802">
<property type="term" value="F:identical protein binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="IntAct"/>
</dbReference>
<dbReference type="GO" id="GO:0046872">
<property type="term" value="F:metal ion binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0042803">
<property type="term" value="F:protein homodimerization activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019901">
<property type="term" value="F:protein kinase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004674">
<property type="term" value="F:protein serine/threonine kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031625">
<property type="term" value="F:ubiquitin protein ligase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051301">
<property type="term" value="P:cell division"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0044257">
<property type="term" value="P:cellular protein catabolic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1903926">
<property type="term" value="P:cellular response to bisphenol A"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006974">
<property type="term" value="P:cellular response to DNA damage stimulus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0035690">
<property type="term" value="P:cellular response to drug"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0071480">
<property type="term" value="P:cellular response to gamma radiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0000077">
<property type="term" value="P:DNA damage checkpoint"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006975">
<property type="term" value="P:DNA damage induced protein phosphorylation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006977">
<property type="term" value="P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006978">
<property type="term" value="P:DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006302">
<property type="term" value="P:double-strand break repair"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000086">
<property type="term" value="P:G2/M transition of mitotic cell cycle"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008630">
<property type="term" value="P:intrinsic apoptotic signaling pathway in response to DNA damage"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042771">
<property type="term" value="P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0090307">
<property type="term" value="P:mitotic spindle assembly"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071157">
<property type="term" value="P:negative regulation of cell cycle arrest"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:2000002">
<property type="term" value="P:negative regulation of DNA damage checkpoint"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0018105">
<property type="term" value="P:peptidyl-serine phosphorylation"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0018107">
<property type="term" value="P:peptidyl-threonine phosphorylation"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:2000210">
<property type="term" value="P:positive regulation of anoikis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001934">
<property type="term" value="P:positive regulation of protein phosphorylation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045893">
<property type="term" value="P:positive regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046777">
<property type="term" value="P:protein autophosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006468">
<property type="term" value="P:protein phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050821">
<property type="term" value="P:protein stabilization"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042981">
<property type="term" value="P:regulation of apoptotic process"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0042176">
<property type="term" value="P:regulation of protein catabolic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1901796">
<property type="term" value="P:regulation of signal transduction by p53 class mediator"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006355">
<property type="term" value="P:regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001302">
<property type="term" value="P:replicative cell aging"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CACAO"/>
</dbReference>
<dbReference type="GO" id="GO:0090399">
<property type="term" value="P:replicative senescence"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1903416">
<property type="term" value="P:response to glycoside"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0042770">
<property type="term" value="P:signal transduction in response to DNA damage"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0072428">
<property type="term" value="P:signal transduction involved in intra-S DNA damage checkpoint"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006351">
<property type="term" value="P:transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="InterPro" id="IPR020636">
<property type="entry name" value="Ca/CaM-dep_Ca-dep_prot_Kinase"/>
</dbReference>
<dbReference type="InterPro" id="IPR000253">
<property type="entry name" value="FHA_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR011009">
<property type="entry name" value="Kinase-like_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR000719">
<property type="entry name" value="Prot_kinase_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR008271">
<property type="entry name" value="Ser/Thr_kinase_AS"/>
</dbReference>
<dbReference type="InterPro" id="IPR008984">
<property type="entry name" value="SMAD_FHA_domain"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR24347">
<property type="entry name" value="PTHR24347"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00498">
<property type="entry name" value="FHA"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00069">
<property type="entry name" value="Pkinase"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00240">
<property type="entry name" value="FHA"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00220">
<property type="entry name" value="S_TKc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF49879">
<property type="entry name" value="SSF49879"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF56112">
<property type="entry name" value="SSF56112"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50006">
<property type="entry name" value="FHA_DOMAIN"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50011">
<property type="entry name" value="PROTEIN_KINASE_DOM"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00108">
<property type="entry name" value="PROTEIN_KINASE_ST"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0053">Apoptosis</keyword>
<keyword id="KW-0067">ATP-binding</keyword>
<keyword id="KW-0131">Cell cycle</keyword>
<keyword id="KW-0132">Cell division</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0227">DNA damage</keyword>
<keyword id="KW-0234">DNA repair</keyword>
<keyword id="KW-0418">Kinase</keyword>
<keyword id="KW-0435">Li-Fraumeni syndrome</keyword>
<keyword id="KW-0460">Magnesium</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0498">Mitosis</keyword>
<keyword id="KW-0547">Nucleotide-binding</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0723">Serine/threonine-protein kinase</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<keyword id="KW-0808">Transferase</keyword>
<keyword id="KW-0043">Tumor suppressor</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="chain" description="Serine/threonine-protein kinase Chk2" id="PRO_0000085858">
<location>
<begin position="1"/>
<end position="543"/>
</location>
</feature>
<feature type="domain" description="FHA" evidence="10">
<location>
<begin position="113"/>
<end position="175"/>
</location>
</feature>
<feature type="domain" description="Protein kinase" evidence="11">
<location>
<begin position="220"/>
<end position="486"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP">
<location>
<begin position="227"/>
<end position="234"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP">
<location>
<begin position="302"/>
<end position="308"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP">
<location>
<begin position="351"/>
<end position="352"/>
</location>
</feature>
<feature type="region of interest" description="T-loop/activation segment">
<location>
<begin position="368"/>
<end position="394"/>
</location>
</feature>
<feature type="active site" description="Proton acceptor">
<location>
<position position="347"/>
</location>
</feature>
<feature type="binding site" description="ATP">
<location>
<position position="249"/>
</location>
</feature>
<feature type="binding site" description="ATP">
<location>
<position position="368"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by PLK3" evidence="44">
<location>
<position position="62"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by ATM and MAP3K20" evidence="15 36 43 44">
<location>
<position position="68"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by PLK3" evidence="44">
<location>
<position position="73"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by autocatalysis" evidence="50">
<location>
<position position="379"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by autocatalysis" evidence="17">
<location>
<position position="383"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by autocatalysis" evidence="17">
<location>
<position position="387"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="48">
<location>
<position position="456"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 13." id="VSP_045148" evidence="64">
<location>
<begin position="1"/>
<end position="221"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 11." id="VSP_014556" evidence="62">
<location>
<begin position="75"/>
<end position="392"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_014559" evidence="62">
<location>
<begin position="107"/>
<end position="487"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 4." id="VSP_014558" evidence="62">
<location>
<begin position="107"/>
<end position="197"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 9." id="VSP_014557" evidence="62 63">
<original>E</original>
<variation>ETESGHVTQSDLELLLSSDPPASASQSAGIRGVRHHPRPVCSLK</variation>
<location>
<position position="107"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 10." id="VSP_014560" evidence="62">
<original>KRTDKYRTYSKKHFRIF</original>
<variation>EFRSYSFYLP</variation>
<location>
<begin position="131"/>
<end position="147"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 10." id="VSP_014561" evidence="62">
<location>
<begin position="148"/>
<end position="543"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 6." id="VSP_014562" evidence="62">
<original>VGPKNSYIAYIEDHSG</original>
<variation>ENLSCPYRIWFNFCLF</variation>
<location>
<begin position="150"/>
<end position="165"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 6." id="VSP_014563" evidence="62">
<location>
<begin position="166"/>
<end position="543"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_014564" evidence="61 62">
<original>VFVFFDLTVDDQSVYPKALRDEYIMSK</original>
<variation>EKILKIYSLSRFSKIRRGAVAHVFNPS</variation>
<location>
<begin position="198"/>
<end position="224"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 5." id="VSP_014565" evidence="62">
<original>FVFFD</original>
<variation>VPVER</variation>
<location>
<begin position="199"/>
<end position="203"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 5." id="VSP_014566" evidence="62">
<location>
<begin position="204"/>
<end position="543"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_014567" evidence="61 62">
<original>SGACGEV</original>
<variation>GRGWQIT</variation>
<location>
<begin position="228"/>
<end position="234"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_014568" evidence="61 62">
<location>
<begin position="235"/>
<end position="543"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 8." id="VSP_014569" evidence="62">
<original>PCIIKIK</original>
<variation>DGRGRAV</variation>
<location>
<begin position="283"/>
<end position="289"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 8." id="VSP_014570" evidence="62">
<location>
<begin position="290"/>
<end position="543"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 12." id="VSP_014571" evidence="62 65">
<location>
<begin position="337"/>
<end position="365"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 7." id="VSP_014572" evidence="62">
<original>YLH</original>
<variation>MKT</variation>
<location>
<begin position="337"/>
<end position="339"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 7." id="VSP_014573" evidence="62">
<location>
<begin position="340"/>
<end position="543"/>
</location>
</feature>
<feature type="sequence variant" description="In an osteogenic sarcoma sample; somatic mutation; might influence susceptibility to breast cancer; does not cause protein abrogation in familial colorectal cancer; dbSNP:rs137853008." id="VAR_019101" evidence="20">
<original>A</original>
<variation>S</variation>
<location>
<position position="17"/>
</location>
</feature>
<feature type="sequence variant" description="In multiple cancers; dbSNP:rs149991239." id="VAR_026630" evidence="22">
<original>T</original>
<variation>K</variation>
<location>
<position position="59"/>
</location>
</feature>
<feature type="sequence variant" description="In prostate cancer; somatic mutation; dbSNP:rs141568342." id="VAR_019107" evidence="27">
<original>E</original>
<variation>K</variation>
<location>
<position position="64"/>
</location>
</feature>
<feature type="sequence variant" description="In an osteogenic sarcoma sample; neutral allele among Ashkenazi Jewish women; dbSNP:rs17883862." id="VAR_019102" evidence="20 39 60">
<original>P</original>
<variation>L</variation>
<location>
<position position="85"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs28909982." id="VAR_022461" evidence="26 29 41">
<original>R</original>
<variation>G</variation>
<location>
<position position="117"/>
</location>
</feature>
<feature type="sequence variant" description="Might influence susceptibility to breast cancer; does not cause protein abrogation in familial colorectal cancer; dbSNP:rs368570187." id="VAR_022462" evidence="26 41">
<original>R</original>
<variation>Q</variation>
<location>
<position position="137"/>
</location>
</feature>
<feature type="sequence variant" description="In prostate cancer; somatic mutation; dbSNP:rs587781667." id="VAR_019108" evidence="27">
<original>R</original>
<variation>P</variation>
<location>
<position position="145"/>
</location>
</feature>
<feature type="sequence variant" description="In colon cancer and LFS2; does not cause protein abrogation in familial colorectal cancer; loss of the ability to interact with and phosphorylate CDC25A and to promote CDC25A degradation in response to ionizing radiation; dbSNP:rs137853007." id="VAR_008554" evidence="13 16 19 29 38 41">
<original>R</original>
<variation>W</variation>
<location>
<position position="145"/>
</location>
</feature>
<feature type="sequence variant" description="Might influence susceptibility to different types of cancer; does not cause protein abrogation in familial colorectal cancer; loss of the ability to interact with and phosphorylate CDC25A and to promote CDC25A degradation in response to ionizing radiation; dbSNP:rs17879961." id="VAR_008555" evidence="13 16 18 27 29 32 33 34 35 37 38 40 41 60">
<original>I</original>
<variation>T</variation>
<location>
<position position="157"/>
</location>
</feature>
<feature type="sequence variant" description="In prostate cancer; somatic mutation; dbSNP:rs72552322." id="VAR_019109" evidence="27">
<original>G</original>
<variation>R</variation>
<location>
<position position="167"/>
</location>
</feature>
<feature type="sequence variant" description="In prostate cancer; somatic mutation; dbSNP:rs77130927." id="VAR_019103" evidence="27 54">
<original>R</original>
<variation>C</variation>
<location>
<position position="180"/>
</location>
</feature>
<feature type="sequence variant" description="In prostate cancer; somatic mutation; dbSNP:rs137853009." id="VAR_019110" evidence="26 27 41">
<original>R</original>
<variation>H</variation>
<location>
<position position="180"/>
</location>
</feature>
<feature type="sequence variant" description="In prostate cancer; somatic mutation; dbSNP:rs137853010." id="VAR_019104" evidence="27">
<original>R</original>
<variation>C</variation>
<location>
<position position="181"/>
</location>
</feature>
<feature type="sequence variant" description="In prostate cancer; somatic mutation; dbSNP:rs121908701." id="VAR_019105" evidence="27">
<original>R</original>
<variation>H</variation>
<location>
<position position="181"/>
</location>
</feature>
<feature type="sequence variant" description="In prostate cancer; germline mutation; dbSNP:rs121908702." id="VAR_019106" evidence="27">
<original>E</original>
<variation>K</variation>
<location>
<position position="239"/>
</location>
</feature>
<feature type="sequence variant" description="In prostate cancer; germline mutation; dbSNP:rs587780189." id="VAR_019111" evidence="27">
<original>I</original>
<variation>F</variation>
<location>
<position position="251"/>
</location>
</feature>
<feature type="sequence variant" description="In prostate cancer; somatic mutation; dbSNP:rs143611747." id="VAR_019112" evidence="27">
<original>R</original>
<variation>H</variation>
<location>
<position position="318"/>
</location>
</feature>
<feature type="sequence variant" description="In prostate cancer; somatic mutation." id="VAR_019113" evidence="27">
<original>T</original>
<variation>P</variation>
<location>
<position position="323"/>
</location>
</feature>
<feature type="sequence variant" description="In prostate cancer; somatic mutation; dbSNP:rs587780194." id="VAR_019114" evidence="27">
<original>Y</original>
<variation>C</variation>
<location>
<position position="327"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs28909980." id="VAR_029154">
<original>D</original>
<variation>N</variation>
<location>
<position position="347"/>
</location>
</feature>
<feature type="sequence variant" description="Confers a moderate risk of breast cancer; partially reduces kinase activity; dbSNP:rs531398630." id="VAR_066012" evidence="54">
<original>H</original>
<variation>Y</variation>
<location>
<position position="371"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; does not phosphorylate p53/TP53; dbSNP:rs200928781." id="VAR_073020" evidence="57">
<original>Y</original>
<variation>C</variation>
<location>
<position position="390"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs200649225." id="VAR_024572">
<original>R</original>
<variation>H</variation>
<location>
<position position="406"/>
</location>
</feature>
<feature type="sequence variant" description="May increase breast cancer risk; dbSNP:rs137853011." id="VAR_022463" evidence="39">
<original>S</original>
<variation>F</variation>
<location>
<position position="428"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs17882922." id="VAR_021117" evidence="60">
<original>L</original>
<variation>M</variation>
<location>
<position position="436"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs17880867." id="VAR_021118" evidence="60">
<original>N</original>
<variation>K</variation>
<location>
<position position="446"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs17881473." id="VAR_021119" evidence="60">
<original>F</original>
<variation>I</variation>
<location>
<position position="447"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs17886163." id="VAR_021120" evidence="60">
<original>I</original>
<variation>S</variation>
<location>
<position position="448"/>
</location>
</feature>
<feature type="sequence variant" description="In prostate cancer; somatic mutation." id="VAR_019115" evidence="27">
<original>T</original>
<variation>K</variation>
<location>
<position position="476"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs28909981." id="VAR_029155">
<original>S</original>
<variation>C</variation>
<location>
<position position="500"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs17883172." id="VAR_021121" evidence="60">
<original>E</original>
<variation>K</variation>
<location>
<position position="501"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs17882942." id="VAR_021122" evidence="60">
<original>L</original>
<variation>V</variation>
<location>
<position position="512"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of activation and phosphorylation." evidence="21 36">
<original>T</original>
<variation>A</variation>
<location>
<position position="68"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impaired activation, phosphorylation by ATM and G2/M transition checkpoint." evidence="44">
<original>S</original>
<variation>A</variation>
<location>
<position position="73"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of kinase activity and of the ability to phosphorylate CDC25A." evidence="16 58">
<original>D</original>
<variation>A</variation>
<location>
<position position="347"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of autophosphorylation activity." evidence="36">
<original>D</original>
<variation>N</variation>
<location>
<position position="368"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abrogates autophosphorylation at Ser-379 and prevents ubiquitination." evidence="50">
<original>S</original>
<variation>A</variation>
<location>
<position position="379"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of phosphorylation in response to ionizing radiation." evidence="17">
<original>T</original>
<variation>A</variation>
<location>
<position position="383"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of phosphorylation in response to ionizing radiation." evidence="17">
<original>T</original>
<variation>A</variation>
<location>
<position position="387"/>
</location>
</feature>
<feature type="mutagenesis site" description="Increased ubiquitination and degradation by the proteasome." evidence="48">
<original>S</original>
<variation>A</variation>
<location>
<position position="456"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="94"/>
<end position="98"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="100"/>
<end position="103"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="106"/>
<end position="108"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="110"/>
<end position="118"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="122"/>
<end position="124"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="128"/>
<end position="132"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="135"/>
<end position="138"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="144"/>
<end position="150"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="154"/>
<end position="162"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="168"/>
<end position="170"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="180"/>
<end position="182"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="187"/>
<end position="193"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="197"/>
<end position="203"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="209"/>
<end position="211"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="214"/>
<end position="219"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="220"/>
<end position="228"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="230"/>
<end position="239"/>
</location>
</feature>
<feature type="turn" evidence="5">
<location>
<begin position="240"/>
<end position="243"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="244"/>
<end position="251"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="253"/>
<end position="256"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="270"/>
<end position="279"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="288"/>
<end position="302"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="307"/>
<end position="309"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="310"/>
<end position="313"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="314"/>
<end position="316"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="321"/>
<end position="340"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="350"/>
<end position="352"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="353"/>
<end position="361"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="364"/>
<end position="366"/>
</location>
</feature>
<feature type="helix" evidence="8">
<location>
<begin position="369"/>
<end position="371"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="379"/>
<end position="385"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="388"/>
<end position="390"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="393"/>
<end position="398"/>
</location>
</feature>
<feature type="turn" evidence="5">
<location>
<begin position="399"/>
<end position="403"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="407"/>
<end position="422"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="429"/>
<end position="431"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="436"/>
<end position="442"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="449"/>
<end position="452"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="457"/>
<end position="466"/>
</location>
</feature>
<feature type="turn" evidence="5">
<location>
<begin position="471"/>
<end position="473"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="477"/>
<end position="481"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="484"/>
<end position="486"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="489"/>
<end position="502"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="504"/>
<end position="506"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1GXC"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2CN5"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2W7X"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2WTJ"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2YCF"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3I6U"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4BDD"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4BDE"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q9Z265"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00086"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00159"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10097108"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10617473"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10724175"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10973490"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11298456"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11390408"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11461078"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11719428"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11746983"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11901158"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12052256"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12094328"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12364621"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12402044"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12454775"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12533788"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12607004"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12610780"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12717439"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12810724"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14612911"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15087378"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15095295"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15239132"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15342622"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15492928"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15535844"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15649950"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15810020"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15818573"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16163388"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16311512"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16481012"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16794575"/>
</source>
</evidence>
<evidence key="46" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17101782"/>
</source>
</evidence>
<evidence key="47" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17380128"/>
</source>
</evidence>
<evidence key="48" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17715138"/>
</source>
</evidence>
<evidence key="49" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18317453"/>
</source>
</evidence>
<evidence key="50" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18644861"/>
</source>
</evidence>
<evidence key="51" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18728393"/>
</source>
</evidence>
<evidence key="52" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19164942"/>
</source>
</evidence>
<evidence key="53" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20364141"/>
</source>
</evidence>
<evidence key="54" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21618645"/>
</source>
</evidence>
<evidence key="55" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24825908"/>
</source>
</evidence>
<evidence key="56" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25361978"/>
</source>
</evidence>
<evidence key="57" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25619829"/>
</source>
</evidence>
<evidence key="58" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9836640"/>
</source>
</evidence>
<evidence key="59" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9889122"/>
</source>
</evidence>
<evidence key="60" type="ECO:0000269">
<source ref="10"/>
</evidence>
<evidence key="61" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="10097108"/>
</source>
</evidence>
<evidence key="62" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15361853"/>
</source>
</evidence>
<evidence key="63" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15461802"/>
</source>
</evidence>
<evidence key="64" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15498874"/>
</source>
</evidence>
<evidence key="65" type="ECO:0000303">
<source ref="7"/>
</evidence>
<evidence key="66" type="ECO:0000305"/>
<sequence length="543" mass="60915" checksum="28890ACF3C1F3408" modified="1999-05-01" version="1">
MSRESDVEAQQSHGSSACSQPHGSVTQSQGSSSQSQGISSSSTSTMPNSSQSSHSSSGTL
SSLETVSTQELYSIPEDQEPEDQEPEEPTPAPWARLWALQDGFANLECVNDNYWFGRDKS
CEYCFDEPLLKRTDKYRTYSKKHFRIFREVGPKNSYIAYIEDHSGNGTFVNTELVGKGKR
RPLNNNSEIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFER
KTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIV
LELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEE
DCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFIC
LSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEA
LRHPWLQDEDMKRKFQDLLSEENESTALPQVLAQPSTSRKRPREGEAEGAETTKRPAVCA
AVL
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>